Abstract
Phase 2 Study of E7777, a Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein, in Japanese Patients with Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have